Table 3. Risk Factors Associated with Late Mortality Compared to Survival in Patients with IPD in Calgary.
Risk Factor | Risk Factor Sub-category | RRR Late Mortality to Survival (95% CI)a | P-value |
---|---|---|---|
Disease Severity Modified by Comorbidities | Less severe disease and Charlson comorbidity index =0 | Reference group | |
More severe disease and Charlson comorbidity index=0 | 21.1 (4.2-105.7) | <0.001 | |
Less severe disease and Charlson comorbidity index=1 | -b | -a | |
More severe disease and Charlson comorbidity index =1 | 22.6 (4.5-113.9) | <0.001 | |
Less severe disease and Charlson comorbidity index ≥2 | 6.1 (1.4-27.7) | 0.018 | |
More severe disease and Charlson comorbidity index ≥2 | 22.4 (4.8-103.9) | <0.001 | |
Age | Per 5 year increase | 1.3 (1.1-1.4) | <0.001 |
Gender | Female | Reference group | |
Male | 0.6 (0.3-1.2) | 0.163 | |
Primary Diagnosis | Bacteremia/other invasive diagnosis | Reference group | |
Pneumonia/empyema diagnosis | 1.0 (0.3-3.1) | 0.990 | |
Meningitis | 3.3 (0.8-14.1) | 0.099 | |
Time to receipt of appropriate antibiotic treatment | <24 hours post-presentation | Reference group | |
24-48 hours post-presentation | 1.2 (0.3-4.3) | 0.776 | |
>48 hours post-presentation | 1.6 (0.4-6.1) | 0.463 | |
No receipt of appropriate antibiotics | 0.8 (0.1-6.7) | 0.863 |
a RRR=Relative Risk Ratio 95% CI = 95% Confidence Interval; b. No inferences can be made with this estimate due to a zero cell.